Skip to main content
. 2009 Nov 11;84(2):856–866. doi: 10.1128/JVI.00692-09

FIG. 2.

FIG. 2.

In vitro oncolytic potency. Human renal cancer cells (786-O) (A), murine renal cancer cells (Renca) (B), and HUVEC (C) were infected with different concentrations of replication-competent or UV-inactivated vaccinia viruses. Three days later, cell viability was measured using an MTS assay. Bars indicate the standard errors.